| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.88B | +10.6% |
| Cost of Revenue | $3.47B | +16.0% |
| R&D Expense | $66.4M | +6.4% |
| SG&A Expense | $772.4M | +4.6% |
| Operating Income | $423.2M | -8.5% |
| Interest Expense | $139.8M | +4.2% |
| Pre-tax Income | $257.3M | -24.4% |
| Income Tax | $65.1M | -14.5% |
| Net Income | $191.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $645.2M | -23.2% |
| Accounts Receivable | $909.3M | +19.6% |
| Inventory | $829.6M | +23.9% |
| Current Assets | $2.69B | +4.5% |
| Total Assets | $7.06B | -2.2% |
| Current Liabilities | $1.38B | +3.7% |
| Long-term Debt | $3.67B | -4.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $293.8M | -47.4% |
| Capital Expenditures | $150.9M | +24.1% |
| Investing Cash Flow | -$106.4M | +85.1% |
| Financing Cash Flow | -$368.9M | -10.3% |
| Free Cash Flow | $142.9M | -67.3% |
| -27.4% |
| EPS (Basic) | $0.86 | -24.6% |
| EPS (Diluted) | $0.86 | -24.6% |
| Total Liabilities |
| $5.56B |
| -2.1% |
| Stockholders' Equity | $1.45B | -2.6% |